Viagra had no impact on saquinavir pharmacokinetics. A more robust CYP3A4 inhibitor which include ketoconazole or itraconazole could be predicted to acquire higher result than that seen with saquinavir. Populace pharmacokinetic information from patients in clinical trials also indicated a reduction in sildenafil clearance when it had been co-admini